Hepatitis C in State Correctional Facilities

Choo, 1989, Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome, Science, 244, 359, 10.1126/science.2523562 1997, Hepatology, 26, 2S, 10.1002/hep.510260701 Alter, M, J, Epidemiology of hepatitis C, 1997 Mar 24, 6, 67, 70 Conry-Cantilena, 1996, Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection, N Engl J Med, 334, 1691, 10.1056/NEJM199606273342602 Ruiz, J, D, Mikanda, J, Seroprevalence of HIV, hepatitis B, hepatitis C, and risk behaviors among inmates entering the California correctional system, Sacramento, California, Department of Health Services, 1996 Mar Alter, 1993, The detection, transmission, and outcome of hepatitis C virus infection, Infect Agents Dis, 2, 155 Brown, 1993 Alter, 1992, The natural history of community-acquired hepatitis C in the United States, N Engl J Med, 327, 1899, 10.1056/NEJM199212313272702 Seeff, 1992, Long-term mortality after transfusion-associated non-A, non-B hepatitis, N Engl J Med, 327, 1906, 10.1056/NEJM199212313272703 Koretz, 1993, Non-A, non-B post-transfusion hepatitis: looking back in the second decade, Ann Intern Med, 119, 110, 10.7326/0003-4819-119-2-199307150-00003 Nishiguchi, 1995, Randomized trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic acute hepatitis C with cirrhosis, Lancet, 346, 1051, 10.1016/S0140-6736(95)91739-X Hoofnagle, 1986, Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon: a preliminary report, N Engl J Med, 315, 1575, 10.1056/NEJM198612183152503 Carithers, R, L, Jr, Therapy of hepatitis C: interferon alpha-2b, 1997 Mar 24, 6, 83, 5 Reichard, 1995, Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alpha-2b treatment, Hepatology, 21, 918 Saracco, 1993, Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-α2b, Hepatology, 18, 1300, 10.1002/hep.1840180603 Davis, 1989, Treatment of chronic hepatitis C with recombinant interferon alpha: a multicenter randomised, controlled trial, N Engl J Med, 321, 1501, 10.1056/NEJM198911303212203 Saracco, 1990, A randomized, controlled trial of interferon alpha-2b as therapy for chronic non-A, non-B hepatitis, J Hepatol, 11, 543, 10.1016/0168-8278(90)90162-K Causse, 1991, Comparison of 1 or 3 MU of interferon alpha-2b and placebo in patients with chronic non-A, non-B hepatitis, Gastroenterology, 101, 497, 10.1016/0016-5085(91)90030-O Cromie, 1996, Chronic hepatitis C: effect of alcohol on hepatic activity and viral titre, J Hepatol, 25, 821, 10.1016/S0168-8278(96)80284-4 Poynard, 1997, Natural history of liver fibrosis progression in patients with chronic hepatitis C, Lancet, 349, 825, 10.1016/S0140-6736(96)07642-8 Shahara, 1996, Hepatitis C, Ann Intern Med, 125, 658, 10.7326/0003-4819-125-8-199610150-00006 Iwarson, 1995, Hepatitis C: natural history of a unique infection, Clin Infect Dis, 20, 1361, 10.1093/clinids/20.5.1361 Farci, 1992, Lack of protective immunity against reinfection with hepatitis C virus, Science, 258, 135, 10.1126/science.1279801 Camp, C, G, Camp, G, M, The corrections yearbook 1996, South Salem, NY, Criminal Justice Institute, 1996 Anno, 1996, A preliminary model for determining limits for correctional health care services, J Correct Health Care, 3, 67, 10.1177/107834589600300105 Dusheiko, 1995, Treatment of chronic type B and C hepatitis with interferon alpha: an economic appraisal, Hepatology, 1863 Shiell, 1994, The cost effectiveness of alpha interferon in the treatment of chronic active hepatitis C, Med J Aust, 268, 10.5694/j.1326-5377.1994.tb125830.x Bennett, 1996, Modeling therapeutic benefit in the midst of uncertainty: therapy for hepatitis C, Dig Dis Sci, 4, 56S, 10.1007/BF02087877 Koff, R, S, Cost-effectiveness analysis, 1997 Mar 24, 6, 137, 9 Skolnick, 1998, Look behind bars for key to control STDs, JAMA, 279, 97, 10.1001/jama.279.2.97 Butler, 1997, Hepatitis B and C in New South Wales prisons: prevalence and risk factors, Med J Aust, 166, 127, 10.5694/j.1326-5377.1997.tb140041.x